Answers are grounded in this paper and cite their sources.
Case report details strain characterization and therapy in Staphylococcus aureus endocarditis with reduced vancomycin susceptibility, highlighting growing clinical challenges.
Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.
No takes yet. Share an insight, caveat, or question.
Woods et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: